UBS Group
SMTI icon

UBS Group’s Sanara MedTech SMTI Stock Holding History

UBS Group’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.4K Sell
356
-2,931
-89% -$60.6K ﹤0.01% 8681
2026
Q1 		$56.5K Sell
3,287
-6,264
-66% -$129K ﹤0.01% 7294
2025
Q4 		$223K Buy
9,551
+5,834
+157% +$151K ﹤0.01% 6520
2025
Q3 		$118K Sell
3,717
-4,078
-52% -$123K ﹤0.01% 7004
2025
Q2 		$221K Buy
7,795
+2,375
+44% +$71.2K ﹤0.01% 6653
2025
Q1 		$167K Sell
5,420
-1,051
-16% -$35.7K ﹤0.01% 6660
2024
Q4 		$215K Buy
6,471
+3,190
+97% +$108K ﹤0.01% 6404
2024
Q3 		$99.2K Buy
3,281
+1,842
+128% +$57.4K ﹤0.01% 6378
2024
Q2 		$40.6K Sell
1,439
-2,620
-65% -$82.3K ﹤0.01% 6847
2024
Q1 		$150K Sell
4,059
-332
-8% -$12.4K ﹤0.01% 6033
2023
Q4 		$180K Buy
4,391
+2,124
+94% +$68.2K ﹤0.01% 5837
2023
Q3 		$70.6K Sell
2,267
-437
-16% -$16.9K ﹤0.01% 6074
2023
Q2 		$108K Buy
2,704
+2,095
+344% +$85.7K ﹤0.01% 5947
2023
Q1 		$25.1K Buy
609
+354
+139% +$14.9K ﹤0.01% 6912
2022
Q4 		$11.6K Buy
255
+55
+28% +$1.9K ﹤0.01% 8377
2022
Q3 		$6K Sell
200
-207
-51% -$5.8K ﹤0.01% 9060
2022
Q2 		$8K Buy
+407
New +$9.5K ﹤0.01% 8345
2022
Q1 		– Sell
-905
Closed -$27K – 10844
2021
Q4 		$27K Buy
905
+330
+57% +$10.4K ﹤0.01% 7504
2021
Q3 		$20K Buy
+575
New +$20.6K ﹤0.01% 7160
2021
Q1 		– Sell
-369
Closed -$18K – 9422
2020
Q4 		$18K Buy
+369
New +$14.5K ﹤0.01% 7019

Other funds holding SMTI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

UBS Group's SMTI Position: Q2 2026 in Review

UBS Group reduced its Sanara MedTech (SMTI) stake by 89% in Q2 2026, selling an estimated $60.6K and leaving 356 shares worth $8.4K. The position accounts for ﹤0.01% of the portfolio, ranked #8681.

UBS Group first reported a position in SMTI in Q4 2020 and has held it in 20 quarters since. The position peaked at $223K in Q4 2025. 74 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

  • UBS Group held 356 shares of Sanara MedTech worth $8.4K as of Q2 2026.
  • UBS Group sold 2,931 Sanara MedTech shares in Q2 2026, an estimated $60.6K.
  • Sanara MedTech made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8681 holding.
  • UBS Group first reported a position in Sanara MedTech in Q4 2020 and has held it in 20 quarters since.
  • UBS Group's Sanara MedTech position peaked at $223K in Q4 2025.
  • 74 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.